Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
430 Leser
Artikel bewerten:
(2)

Altair Engineering Expands Defense and Healthcare and Life Sciences Segment Leadership

Appointment of Caroline Phares and Chip Colbert to bolster Altair's industry expertise

TROY, Mich., Feb. 22, 2024 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, announced that Chip Colbert and Caroline Phares have joined Altair in leadership roles for two priority industry segments. Phares has been named vice president for healthcare and life sciences (HLS) and Colbert has been named senior director for Federal and Department of Defense (DoD), part of Altair's aerospace and defense vertical. Both individuals bring decades of valuable experience that will further propel Altair's industry efforts.

Altair has named Chip Colbert senior director for Federal and Department of Defense (DoD) and Caroline Phares vice president for healthcare and life sciences.

"Chip and Caroline's proven experience will further bolster our focus on high-growth industry segments, helping us expand Altair's market share in segments where we have best-in-class technology, a strong track record of success, and a unique blend of talent," said James R. Scapa, co-founder and chief executive officer, Altair. "Adding these two leaders is another demonstration of our commitment to investing in high-potential industries."

With more than 20 years of experience, Caroline Phares will elevate Altair's presence and enhance its focus in the HLS sector. Prior to joining Altair, she served as the global head of health and life sciences at Domino Data Lab. Prior to joining Domino, she served as the product director of quantitative decision-making at GSK, where she was responsible for leading a transformational biostatistics program which modernized technology, processes, and skills to accelerate analysis and reporting for clinical trials submissions and leveraged data assets for faster decision-making and continuous improvement. Phares is a graduate of Villanova University and holds a bachelor of science degree in comprehensive science, physics, and mathematics.

As a seasoned national security, military, and business leader with decades of experience, Chip Colbert will expand Altair's Federal and Department of Defense customer portfolio. Previously, he served as the vice president for the Department of Defense and the Intelligence Community for Virtualitics, Inc. and as the senior director of U.S. sales for Rebellion Defense. In both roles, Colbert was responsible for defining go-to-market strategy and establishing teams to deliver commercial growth. Prior to his private sector roles, Colbert worked in the White House, serving as the National Security Council's director for defense policy and strategy for the Middle East. Over a 20-year career as an Army infantry officer and strategist, he was deployed worldwide in support of military operations. He is a graduate of the United States Military Academy and holds a master's degree in organizational psychology and leadership development from Columbia University's Teachers College.

For more information on Altair's focus on aerospace and healthcare and life sciences, visit https://altair.com/aerospace and https://altair.com/healthcare.

About Altair

Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world - all while creating a greener, more sustainable future. For more information, visit https://www.altair.com/.

Media contacts


Altair Corporate

Altair Investor Relations

Bridget Hagan

Monica Gould, The Blueshirt Group

+1.216.769.2658

+1 212.871.3927

corp-newsroom@altair.com

ir@altair.com



Altair Europe/The Middle East/Africa


Charlotte Hartmann


+49 7031 6208 0


emea-newsroom@altair.com


Altair

Photo - https://mma.prnewswire.com/media/2342585/Altair_ChipColbert_and_CarolinePhares.jpg
Logo - https://mma.prnewswire.com/media/1421069/Altair_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/altair-expands-defense-and-healthcare-and-life-sciences-segment-leadership-302065043.html

© 2024 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.